跳至主要内容
临床试验/NCT04423991
NCT04423991已完成不适用

Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning: the IDENTIFY Trial

Dascena2 个研究点 分布在 1 个国家目标入组 290 人开始时间: 2020年3月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
290
试验地点
2
主要终点
Mortality outcome

研究概览

简要总结

The purpose of this study was to assess the performance of a machine learning algorithm which identifies patients for whom hydroxychloroquine treatment is associated with predicted survival.

详细描述

In a multi-center pragmatic clinical trial, COVID-19 positive patients admitted to 6 United States medical centers were enrolled between March 10 and June 4, 2020. A machine learning algorithm was used to determine which patients were suitable for treatment with hydroxychloroquine.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient admitted to covered ward and tested positive for COVID-19
  • Patient had COViage applied to electronic health record data within four hours of COVID-19 test

排除标准

  • Patient not admitted to covered ward or tested negative for COVID-19
  • Patient had COViage applied to electronic health record data greater than four hours after COVID-19 test

结局指标

主要结局

Mortality outcome

时间窗: Through study completion, an average of 3 months

Time to in-hospital death

次要结局

未报告次要终点

研究者

发起方
Dascena
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Identification of a Responsive Subpopulation to... | 临床试验